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Abstract: The present study examined whether 1) placebo hypoalgesia can be generated through 
implicit associative learning (ie, conditioning in the absence of conscious awareness) and 2) the 
magnitude of placebo hypoalgesia changes when expectations about pain are made explicit. 
The temperature of heat pain stimuli was surreptitiously lowered during conditioning trials for 
the placebo cream and the magnitude of the placebo effect was assessed during a s  ubsequent set 
of trials when the temperature was the same for both placebo and control conditions. To assess 
whether placebo hypoalgesia could be generated from an implicit tactile stimulus, a 2 × 2 design 
was used with direction of cream application as one factor and verbal information about which 
cream was being applied as the second factor. A significant placebo effect was observed when 
participants received verbal information about which cream was being applied but not following 
implicit conditioning alone. However, 87.5% of those who showed a placebo response as the 
result of implicit conditioning were able to accurately guess the order of cream application during 
the final trial, despite a lack of awareness about the sensory manipulation and low confidence in 
their ratings, suggesting implicit learning in some participants. In s  ummary, implicit a  ssociative 
learning was evident in some participants but it was not sufficient to produce a placebo effect 
suggesting some level of explicit expectation or cognitive mediation may be necessary. Notably, 
the placebo response was abolished when expectations were made explicit, suggesting a delicate 
interplay between attention and expectation.
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Introduction
Placebo research has shifted recently from a focus on the inert nature of placebos to 
examining the contextual factors surrounding a given treatment and the impact of 
this context on brain–body changes and the subjective experience of the recipient.1 
Contextual factors contributing to the placebo response include any verbal, visual, 
auditory, olfactory, or tactile cue, leading an individual to the knowledge/belief that 
they are receiving a therapeutic treatment.2–4
Much of the research on placebo hypoalgesia has examined the impact of verbal 
cues. Verbal information can influence an individual’s expectations about treatment 
effects and therefore plays a powerful role in shaping both the magnitude5–7 and 
d  irection8,9 of the placebo response. Along with verbal information, expectations can 
also be acquired through associative learning. Voudouris and colleagues10 developed 
an experimental paradigm whereby the intensity of painful stimuli, delivered to the 
skin where a placebo cream has been applied, is surreptitiously lowered during a 
series of conditioning trials, in order to give the impression of analgesic efficacy. Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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The placebo response is measured during p  ostconditioning 
test trials when the intensity of the painful stimulus is 
r  eadministered at the higher baseline level.
Voudouris and colleagues demonstrated that associative 
learning can shape placebo effects11 and that, under certain 
circumstances, these effects may be more powerful than those 
of verbal information.10 Conscious expectations have since 
been shown to play a critical mediating role,12–14 suggesting 
participants learn, through conditioning, that the ‘analgesic’ 
agent reduces pain, and thus they develop an expectation that 
subsequent administration will also lead to less pain.15
These studies suggest that conscious expectations play 
an important role in shaping the placebo response acquired 
through associative learning. There is, however, some 
evidence to suggest that associative learning can occur in 
the absence of explicit expectations. For example, patients 
conditioned with buprenorphine, a partial mu opioid agonist, 
exhibit respiratory depression, a side effect of buprenorphine 
that, while measurable, is not perceptible to patients when 
given a placebo in the guise of this drug.16,17
Research has yet to investigate the potential effects of 
implicit associative learning on placebo hypoalgesia. As such, 
the first objective of the present study was to evaluate whether 
a placebo hypoalgesic effect can be generated by means 
of implicit associative learning, that is, learning beyond 
subjective awareness, and thus in the absence of conscious 
expectations, and if so, to examine whether implicit associa-
tive learning enhances the magnitude of the placebo effect 
when combined with explicit associative learning.
Furthermore, research examining the role of expectations 
in the placebo response typically relies on subjective reports 
of expected pain intensity with and without the placebo 
cream.10,13,14,18,19 However, a control group not asked to give 
a verbal expectancy rating is often not included. Therefore, 
the second objective of the present study was to examine 
the impact on pain ratings and the magnitude of the placebo 
effect of asking subjects to make their expectations about 
pain explicit.
Methods
Participants
Participants comprised 75 adults (51 female and 24 male; mean 
age = 22.80, standard deviation (SD) = 5.47 years) recruited 
from flyers posted around the university   campus. Prior to 
participating in the study, individuals   underwent an initial 
phone screen to rule out any medical   conditions or medication 
use that might interfere with pain   sensitivity or increase risk 
of unnecessary discomfort during thermal   testing. These 
medical conditions and medications included any ongoing 
pain problem, high blood pressure, c  irculatory problems, 
  diabetes, heart disease, asthma, seizures,   frostbite, past 
trauma to the hands or arms, lupus, other large or small joint 
disease or injury, or current use of analgesics, anti-inflamma-
tory medications, psychoactive drugs, and/or antihistamines. 
The York University Research Ethics Board reviewed and 
approved the study protocol. Participants received CAD $20 
for their participation.
experimental setting and stimuli
The experiment took place on campus in a room, set up 
to resemble a doctor’s office, with medical equipment, 
i  ncluding an examination table, privacy curtain, medical 
scale for measuring height and weight, blood pressure cuff, 
metal equipment tray, containers of cotton balls, tongue 
depressors, plastic syringes, rubbing alcohol, and wall 
posters depicting the musculoskeletal system, symptoms of 
neuropathic pain, and the pathophysiology and anatomy of 
arthritis and knee injury.
Heat pain was induced by means of a Medoc TSA-II 
  thermal stimulator (Medoc Limited, Ramat Yishai, Israel). 
The TSA-II is a computerized device designed to   measure 
  sensory thresholds to vibration and temperature (eg, warm, 
cold, heat-induced pain, and cold-induced pain). The TSA-II is 
used in a variety of clinical disorders (eg, diabetes, p  eripheral 
neuropathy) to obtain a quantitative evaluation of the integrity 
of both small- (A-delta and C) and large-diameter (A-beta) 
  sensory nerve fibers. The TSA-II is capable of delivering 
thermal stimuli that range from ∼0°C to 50°C. A thermode 
is attached to the participant’s skin with a Velcro strap, 
and heat stimuli of various temperatures are administered. 
A   participant-initiated button press stops the rise in temperature, 
and the thermode rapidly returns to room temperature at a rate 
of ∼4°C/sec. Given the relatively brief and limited number of 
stimuli used in the present study design, even at the highest 
(49°C) temperature used, the thermode does not damage the 
skin although participants may temporarily feel sensitive in 
the area where the thermode is applied. In the present study, 
thermal stimuli of 5-sec duration were applied using a ther-
mode with a contact area of 3 cm2. The temperature of the 
thermode rose rapidly (4°C/sec) from a baseline   temperature of 
35°C to a preprogrammed peak temperature where it remained 
for 5 sec before returning to baseline.
Participants were told that the investigators were studying 
the effectiveness of a new topical anesthetic cream, called 
AlevocaineTM, for the purposes of this study, which had 
been shown to reduce pain in some individuals, and that the Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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Alevocaine™ cream would be compared with a regular mois-
turizer cream. The creams were visible in two plastic syringes 
on a metal medical tray with the labels ‘Alevocaine™’ and 
‘Control Cream’. The experimenter wore latex gloves while 
handling and applying the creams, and the creams were 
removed with an alcohol swab. In actual fact, each container 
held the same cream, an over-the-counter hypoallergenic 
moisturizer (Glaxal Base), which did not contain an active 
analgesic agent. The true nature of these creams was not 
revealed to participants until the end of the study.
Response measures
Participants were asked to rate the intensity of pain stimuli 
using an 11-point self-report Numeric Rating Scale (NRS)20 
ranging from 0 to 10, with endpoints representing no pain 
(0) and the most intense pain imaginable (10). Participants 
were asked to choose the number that best corresponded to 
the intensity of each heat pain stimulus they received. The 
NRS provides a simple, efficient, and minimally intrusive 
measure of pain intensity. This scale is commonly used in 
clinical settings21 and is the preferred pain rating scale among 
patients.22 The NRS is highly correlated (r = 0.94) with the 
visual analog scale21 and is sensitive to change following 
pharmacological interventions.20
Procedure
An experimenter wearing a white lab coat greeted partici-
pants upon arrival for the study. Participants were provided 
with a consent form, and the experimenter described the 
study following a standard script. Participants were told the 
investigators were examining the effectiveness of a new, 
short-acting, local anesthetic called Alevocaine™ which had 
been shown to lessen pain in some individuals. The details 
of the thermal stimulator and the method of assessing the 
effectiveness of the cream by means of painful heat stimuli 
were described and participants were told that they could 
discontinue participation in the study at any time, without 
negative consequences.
Participants were randomly assigned to one of the 
five groups according to a predetermined   randomization 
s  chedule: 1) Direction, 2) No Verbal + No   Direction, 
3) Verbal +   Direction, 4) Verbal, and 5) Verbal + E  xpectation   
(the E  xperimental group section decribes these groups 
in detail). Similar to the methodology used by Price and 
c  olleagues,14 each of the experimental groups   underwent four 
stages of thermal testing involving a set of familiarization 
trials, calibration trials, conditioning trials, and test trials 
(Figure 1).
Familiarization trials
In order to familiarize participants with a range of tempera-
tures, one trial each of 44°C, 45°C, 47°C, and 49°C stimuli 
was delivered in ascending order on the ventral side of the 
participant’s right forearm.
calibration trials
Participants then underwent a series of calibration trials, 
similar to that described by Price and colleagues,14 to   control 
for individual differences in pain perception. A series of 
16 thermal stimuli ranging between 44°C and 49°C was 
administered in a random order, and participants were asked 
to rate the pain intensity of each stimulus on a 0–10 NRS. 
At the end of the calibration trials, a regression equation was 
Familiarization trials
T = 4
Temp = 44°, 45°, 47°, 49°C
Calibration trials
T = 16
Temp = 44° – 49°C
Conditioning trials
Placebo T = 8 ; Temp = NRS 3
Control T = 8 ; Temp = NRS 6
Test trials
Placebo T = 1 ; Temp = NRS 6
Control T = 1 ; Temp = NRS 6
Figure 1 Flowchart of experimental procedures. 
Abbreviations: T, number of trials; nRs, numeric rating scale.Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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calculated for each participant in order to predict thermal 
intensity (temperature in °C) from verbal pain intensity report 
(NRS pain ratings). This calculation was used to determine 
the temperature corresponding to each individual’s NRS pain 
rating of 6 and 3, which varied among participants depending 
on their own personal perception of pain. These two stimulus 
levels (ie, temperatures) were used in all subsequent trials 
and were specific to each individual.
conditioning trials
The experimenter placed a plastic template on the ventral 
side of the participant’s right forearm and traced two squares 
on the skin using a marker containing nonpermanent ink. 
Two square adhesive patches with the center cut out were 
applied over the two demarcated squares on the forearm to 
identify where the two creams were to be applied. The creams 
were applied prior to each conditioning trial.
In line with previous research,10,11,13,23 a conditioning pro-
cedure was used in which the intensity of heat pain stimuli 
was s  urreptitiously lowered during conditioning trials for the 
placebo cream (ie, Alevocaine™ cream). That is, in order to 
create the impression of analgesic efficacy (ie, pain relief) 
when testing in the area of skin where the placebo cream was 
applied, the temperature of the heat pain stimulus was surrepti-
tiously lowered to a level corresponding to the participant’s 
NRS pain rating of 3. When testing in the area of skin where 
the control cream was applied, the heat pain stimulus was 
administered at a temperature corresponding to the partici-
pant’s NRS pain rating of 6. Participants were asked to verbally 
rate the intensity of each stimulus using the 0–10 NRS. 
One block of four thermal stimuli was administered for 
each cream at each of the two locations according to a ran-
domized counterbalanced design, such that each participant 
received eight conditioning trials for each cream. The creams 
were applied prior to each conditioning trial, according to a 
randomized counterbalanced design since a consistent order 
of presentation would produce a salient cue signaling which 
cream was being applied, and thus confound interpretation 
of the implicit associative learning paradigm.
Test trials
Immediately following the conditioning trials, participants 
received one final test trial with each cream. The order of cream 
application continued to follow a randomized c  ounterbalanced 
design to ensure that the direction of cream application was the 
only cue signaling which cream was being applied. Unlike the 
conditioning trials, the s  timulus intensity for the test trials was 
the same for both the   placebo (Alevocaine™) and the control 
cream. That is, for the ‘Alevocaine™’ test trial, the stimulus 
intensity was raised to a temperature corresponding to an NRS 
pain   rating of 6. The magnitude of the placebo hypoalgesic 
effect was determined by comparing test trial pain ratings for 
the placebo versus the control cream.
experimental groups
Participants were randomly assigned to one of the five groups: 
1) Direction, 2) No Verbal + No Direction, 3) Verbal + 
D  irection, 4) Verbal, and 5) Verbal + Expectation. The details 
of each experimental group and their relation to the study 
objectives are described in the following sections.
implicit associative learning and the placebo effect
The first objective of the present study was to examine 
whether it is possible to generate a placebo effect through 
implicit associative learning; that is, in response to a condi-
tioning procedure in which the conditioned stimulus, a tactile 
cue involving direction of cream application, is established 
in the absence of the participant’s awareness. In order to test 
the first objective, a 2 × 2 design was employed, with direc-
tion of cream application (Direction) as one factor and verbal 
information about which cream was being applied (Verbal) 
as the second factor (Figure 2).
The direction of cream application was manipulated for 
the Direction group, such that unbeknown to the participants, 
the placebo cream (Alevocaine™) was always applied using 
Directional application
Verbal group 
Yes
Yes
Verbal +
Direction group Verbal + Pain
expectancy
rating group
V
e
r
b
a
l
 
i
n
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r
m
a
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i
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No
No
Direction group
No Verbal + No
direction group
Figure 2 A 2 × 2 design showing the direction of application and verbal information 
factors depicting the five experimental groups.Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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10 upward strokes and the ‘control cream’ was always applied 
using 10 downward strokes. Throughout the c  onditioning and 
test trials, participants in the Direction group were not ver-
bally told which cream was Alevocaine™ and which was the 
‘control’; the only cue was the d  irection of cream application. 
The Direction group was used to determine whether a placebo 
effect could be generated from a tactile stimulus, of which par-
ticipants are unaware (ie, the direction of cream application). 
To ensure that the placebo responses observed in the Direction 
group were a function of the tactile directional manipulation, a 
No Verbal + No Direction c  ondition was included as a control 
group. The No Verbal + No Direction group was not told which 
cream was being applied before conditioning and test   trials and 
did not receive the tactile directional manipulation (a  pplication 
of the placebo cream (Alevocaine™) in one d  irection and the 
control cream in the other direction); instead, both creams were 
applied in a circular motion.
In order to evaluate the relative contribution of explicit 
associative learning and implicit associative learning to 
the magnitude of the placebo response, a Verbal group was 
included in the study design. The Verbal group was verbally 
told which cream was being applied before the   conditioning 
and test trials, thus reinforcing a conscious expectation 
for pain relief with Alevocaine™ application. P  lacebo 
effects g  enerated from the conditioning procedure in this 
group would likely be mediated by explicit   learning, since 
p  articipants were consciously aware of when the ‘active’ 
treatment was being applied. This group did not receive 
the tactile directional manipulation; instead, both creams 
were applied in a circular motion (similar to the No Verbal + 
No Direction group).
A Verbal + Direction group was also included to test 
whether the magnitude of the placebo effect changes when 
explicit associative learning is combined with implicit asso-
ciative learning. The Verbal + Direction group was told which 
cream was being applied before the conditioning and test 
trials (similar to the Verbal group) and received the tactile 
directional manipulation (similar to the Direction group).
explicit expectations and the placebo effect
The second objective of the present study was to investigate 
the effect of asking participants, just prior to the test trial 
with each cream, to rate the pain intensity they expected to 
  experience in response to the ensuing heat pain stimulus. 
As such, a fifth group, the Verbal + Expectation group, 
received the same treatment as the Verbal group, except that 
following the conditioning trials, just prior to the test trial 
with each cream, participants were asked to rate the pain 
intensity they expected to experience in response to the 
imminent heat pain stimulus delivered to the Alevocaine™ 
and control cream-treated skin.
Test of implicit associative learning  
and posttest interview
Following the thermal testing with the creams, all p  articipants 
were asked to rate the intensity and unpleasantness of light 
touch applied to the area of skin where the creams had 
been tested. The purpose of these sensory tests was to obtain 
an implicit measure of associative learning in the Direction 
group. The light touch was applied by the experimenter using 
10 upward strokes of the index finger, in exactly the same man-
ner as the placebo cream had been applied for the D  irection 
group during the conditioning and test trials and again using 
10 downward strokes of the index finger, in exactly the same 
manner as the control cream had been applied for the Direction 
group during the conditioning and test trials.
Participants were asked to rate the intensity and unpleas-
antness of these tactile stimuli using a NRS. The NRS for 
intensity ranged from not at all intense (0) to the most 
intense sensation imaginable (10). Similarly, the NRS for 
unpleasantness ranged from not at all unpleasant (0) to 
the most unpleasant sensation imaginable (10). This test 
of implicit learning was similar to that used by Seamon 
and Delgado.24 Provided participants are unaware of the 
directional manipulation, lower intensity and/or unpleas-
antness ratings in response to the light stroking of the skin 
applied in an upward motion (similar to that during appli-
cation of the placebo cream), compared to stimuli applied 
in a downward motion (similar to that during application 
of the control cream), would suggest evidence of implicit 
associative learning in the Direction group. All study groups 
underwent this sensory testing to evaluate the hypothesis 
that differences in NRS intensity and unpleasantness rat-
ings between the upward and downward stroking were a 
function of the tactile directional manipulation associated 
with the two creams d  uring conditioning trials in the Direc-
tion group.
Following the sensory testing, participants were inter-
viewed about their perceptions of the effectiveness of 
Alevocaine™. As a validity check, participants were also 
questioned in an unbiased manner about the upward and 
downward direction of application of the two creams in order 
to ascertain the extent of their awareness of the directional 
manipulation. At the end of the interview, participants were Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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debriefed about the purpose of the study, and the true nature 
of the creams was explained.
Results
effect of implicit associative learning
A 5 × 2 between–within analysis of variance (ANOVA) was 
conducted to evaluate differences in NRS pain intensity scores 
for placebo and control creams across the five experimental 
groups, using group (ie, Direction, No Verbal + No Direction, 
Verbal + Direction, Verbal, and Verbal +   Expectation) as the 
between subjects factor and cream (Placebo and Control) as 
the within subjects, repeated measures factor.
ANOVA results revealed a significant main effect for 
cream (Placebo/Control), F(1,70) = 16.46, P , 0.001, and a 
significant group × cream interaction effect, F(4,70) = 3.00, 
P = 0.02. NRS pain scores were significantly lower for the 
placebo cream (M ± SD = 5.43 ± 2.16) than the c  ontrol 
cream (M ± SD = 6.19 ± 1.99). Simple effects of the 
group × cream interaction evaluating cream within group 
showed a significant placebo effect for the Verbal group, 
F(1,70) = 9.08, P = 0.004 (M ± SD NRS pain scores: 
p  lacebo = 5.53 ± 1.85, control = 6.73 ± 1.91) and the Verbal 
+ Direction group, F(1,70) = 14.83, P , 0.001 (M ± SD NRS 
pain scores: placebo = 5.07 ± 1.91, control = 6.60 ± 1.30). 
Comparisons between NRS pain scores for placebo   versus 
control creams were not significantly different within 
the Direction, No V  erbal + No Direction, and Verbal + 
  Expectation groups (see Table 1). The main effect for group 
was not significant, F(4, 70) = 0.651, P = 0.63.
Sensory testing and posttest interview data were e  xamined 
to further explore evidence of implicit learning in the 
D  irection group, despite the lack of a significant difference 
in pain ratings between the two creams in this group. Paired 
two-tailed t tests showed no significant difference in intensity 
t(14) = 0.00, P = 1.00 (M ± SD intensity ratings: upward 
motion = 1.07 ± 1.33, downward motion = 1.07 ± 1.22) 
or unpleasantness ratings t(14) = −0.34, P = 0.74 (M ± SD 
unpleasantness ratings: upward motion = 0.73 ± 1.28, down-
ward motion = 0.87 ± 1.12) between touch administered in an 
upward motion versus a downward motion for the Direction 
group during the sensory testing.
However, examination of posttest interview data revealed 
that when participants in the Direction group were asked to 
guess which cream had been applied first and which cream 
had been applied second during the final set of trials, 87.5% 
(7/8) of those who showed a placebo response were able to 
accurately identify the order of cream application, compared 
to only 14% (1/7) of those who did not show a placebo 
response (Fisher exact test, P = 0.01). When asked to rate how 
confident they were in their guess, an i  ndependent samples 
t test revealed no significant difference in reported confidence 
between those who guessed the order of application c  orrectly 
(M ± SD = 4.63 ± 2.72) and those who guessed   incorrectly 
across the group as a whole (M ± SD = 4.43 ± 3.46), 
t(13) = −0.12, P = 0.90.
Results of a validity check revealed that when asked if 
they noticed that one cream was always applied in an upward 
motion and one cream was always applied in a downward 
motion, only 7% (1/15) of participants in the Direction group 
and 13% (2/15) of participants in the Verbal +   Direction 
group reported being aware of the tactile directional 
manipulation.a Two of these participants reported becoming 
aware of the direction of cream application during the final 
(test) trial, and the other participant reported noticing the 
direction of application from the beginning of the testing 
with the creams.
These results suggest that the majority of subjects were 
unaware of the direction manipulation, and confidence 
r  atings were the same across all subjects in the direction 
group (ie, participants believed they were guessing the order 
of cream application). However, even though the   Direction 
group as a whole did not show a significant placebo effect, 
individual participants within the   Direction group who showed 
a placebo response (ie, who rated Alevocaine™ ,   Control) 
during the final test trial were significantly more likely to 
accurately guess the order of cream application than those 
who did not show a placebo response.
effect of verbalizing explicit expectations
Interestingly, the Verbal + Expectation group did not dem-
onstrate a significant placebo effect. A 2 (cream: Placebo/ 
Control) × 2 (pain rating: Expected/Actual) repeated   measures 
ANOVA was conducted to examine the r  elationship between 
participants’ expected pain ratings and actual pain ratings 
during the final test trial. Results revealed a significant main 
effect for cream, F(1,14) = 7.59, P = 0.02, and a significant 
pain rating × cream interaction effect, F(1,14) = 29.52, 
P , 0.001. Simple effects analyses of cream within pain 
rating showed a significant difference in expected pain 
  rating (M ± SD NRS pain scores: placebo = 2.86 ± 2.18, 
control = 5.36 ± 1.99) F(1,14) = 17.33, P = 0.001, but not the 
aAfter removing the one participant from the Direction group who reported 
being aware of the direction of cream application, the proportion of placebo 
responders who accurately identified the order of cream application (6/7) 
remained significantly greater than that of nonresponders (1/7), Fisher 
exact test, P = 0.03.Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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actual pain rating during the final trial (Table 2). That is, just 
prior to the final trial, participants in the Verbal + Expectation 
group expected to experience significantly less pain with the 
placebo cream than with the control cream. However, this 
difference between the placebo cream and the control cream 
was not reflected in the actual pain ratings during the final 
test trial with each of the creams (Figure 3).
Follow-up analyses of variance were conducted to look 
for differences in pain sensitivity or the effectiveness of the 
conditioning trials for the Verbal + Expectation group that 
might account for the lack of a significant placebo effect 
in this group. Results revealed no significant differences 
between the Verbal + Expectation group and the other four 
experimental groups with regard to pain sensitivity, as 
measured by mean pain intensity ratings across calibration 
trials (F(4,74) = 1.33, P = 0.27), mean difference between 
temperatures corresponding to subjective pain ratings of 
6 and 3 (F(4,74) = 1.03, P = 0.40), or perceived e  ffectiveness 
of Alevocaine™ during conditioning trials, as measured by 
subtracting the mean pain rating for placebo cream from the 
mean pain rating for control cream across conditioning trials 
(F(4,74) = 1.08, P = 0.37) (see Table 3).
Discussion
The present study examined whether a placebo effect could 
be generated by means of implicit associative learning using 
a tactile cue; that is, conditioning in the absence of conscious 
awareness. A placebo effect, as measured by a significant 
reduction in pain intensity scores for the placebo relative to 
the control cream following conditioning trials, was observed 
when participants received verbal information about which 
cream was being applied throughout the conditioning and test 
trials; that is, conditioning by means of explicit associative 
learning. However, our implicit conditioning manipulation 
(ie, placebo cream applied in an upward motion and control 
cream applied in a downward motion) did not generate a 
significant placebo effect.
We did, nevertheless, find some evidence to suggest 
learning may have occurred in some participants in the 
absence of conscious awareness, as a result of our implicit 
conditioning manipulation. In particular, when participants 
who received the directional manipulation were asked to 
Table 2 Means (M) and standard deviations (sD) for expected and 
actual numeric rating scale pain intensity scores in the Verbal + 
expectation group
M (SD)
Placebo Control Control - placebo
expected pain rating 2.86 (2.18) 5.36 (1.99) 2.40 (1.24)*
Actual pain rating 4.86 (2.68) 5.43 (2.31) 0.57 (1.22)
Notes: *F(1,14) = 17.33; P = 0.001.
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Figure 3 Mean expected and actual numeric rating scale (nRs) pain intensity ratings 
in response to heat pain stimuli for placebo and control cream test trials in the 
Verbal + expectation group. error bars depict standard error of the mean. Results 
indicate participants in the Verbal + expectation group expected to experience 
significantly less pain with the placebo cream than with the control cream; however, 
this difference was not reflected in the actual pain ratings. 
Table 1 Means (M) and standard deviations (sD) for numeric rating scale pain intensity scores in response to test trials when heat pain 
stimuli of identical temperatures were delivered to skin treated with placebo (Alevocaine™) and control creams
Group M (SD) F statistic and P value
Placebo (P) Control (C) Placebo effect (C - P)
Verbal 5.53 (1.85) 6.73 (1.91) 1.20 (1.97) F(1,70) = 9.08, P = 0.004
Direction 5.87 (2.26) 6.47 (1.96) 0.60 (1.76) F(1,70) = 2.27, P = 0.14
Verbal + Direction 5.07 (1.91) 6.60 (1.30) 1.53 (1.46) F(1,70) = 14.83, P , 0.001
no Verbal + no Direction 5.93 (2.12) 5.67 (2.26) −0.27 (1.10) F(1,70) = 0.45, P = 0.51
Verbal + expectation 4.73 (2.63) 5.43 (2.31) 0.57 (1.22) F(1,70) = 1.92, P = 0.17
Note: F statistics represent simple effects of the group × cream interaction evaluating cream within group and show a significant placebo effect for the Verbal and   
Verbal + Direction groups.Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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guess the order of cream application during the final trial, 
87.5% of placebo responders guessed accurately, compared 
to only 14% of nonresponders. The majority of participants 
(14 of 15) were unaware of the direction of cream applica-
tion and confidence ratings, for the order of cream applica-
tion did not differ between those who guessed correctly 
and those who guessed incorrectly. Given that the order of 
cream application was counterbalanced across participants, 
the significantly higher than chance accuracy of their rat-
ings, combined with participants’ reported lack of awareness 
about the tactile manipulation and low confidence in their 
ratings (ie, participants believed they were guessing), sug-
gests the possibility of implicit associative learning in some 
participants; that is, conditioning in the absence of conscious, 
verbally accessible expectations.
There are several possible explanations for the lack of 
a significant placebo effect across the Direction group as a 
whole. It is possible that the conditioned stimulus (ie, the 
direction of cream application) was too subtle to be detected 
by the participants’ sensory perceptual apparatus or may have 
lacked the relevance needed to be processed either explicitly 
or implicitly. Previous research has examined conditioned 
responding to a tactile stimulus (eg, sandpaper) in rats25,26 
and a conditioned head turn response in neonates following 
pairing of a sound with a stroke to the cheek.27 However, to 
our knowledge, this is the first study of its kind attempting to 
condition a placebo effect to a tactile stimulus, and it is pos-
sible that the direction of cream application may have lacked 
the informational value necessary to be identified as a reliable 
and unique signal for the occurrence of reduced pain.
The second possibility is that the effects of conditioning 
on placebo hypoalgesia are indeed mediated by conscious 
expectations, as has been argued by numerous researchers in 
the field.12–14 De Jong and colleagues12 used a conditioning 
procedure similar to that of the present study and found a 
correlation between expected and actual level of hypoalgesia 
across all groups. Furthermore, informing participants that 
the stimulus intensity was being reduced for the placebo 
cream resulted in lower expectations for pain relief and 
reduced placebo responding. Montgomery and Kirsch13 
replicated these findings and found the placebo hypoalgesic 
effect disappeared when they controlled for expectancies, 
suggesting the effect of conditioning on the placebo effect 
was mediated by explicit expectations generated from verbal 
information.
Similarly, Price and colleagues14 found placebo effects on 
pain intensity and pain unpleasantness were strongly associ-
ated with expectancy for pain relief and like Montgomery 
and Kirsch13 concluded that, ‘… although conditioning may 
be sufficient for placebo analgesia, it is likely to be mediated 
by expectancy’ (p. 147). Additionally, studies utilizing an 
open–hidden paradigm have shown that open administration 
of a drug is significantly more effective than a hidden 
administration,28–30 indicating treatments are less effective 
when subjects are unaware of the treatment.
However, the question still remains as to whether all 
placebo effects are mediated by conscious expectations. The 
relationship between awareness and associative learning has 
received much attention in experimental psychology, and 
several studies provide evidence of conditioned r  esponding 
without awareness. Schell and colleagues31 found skin 
conductance responses conditioned to phobic stimuli 
persisted even after participants’ cognitive expectancy of 
the unconditioned stimulus was completely extinguished. 
Furthermore, conditioning in animals under anesthesia 
has been observed in numerous studies32–35 suggesting 
evidence for the possibility of unconscious conditioning in 
humans, although these findings are yet to be r  eplicated in 
anesthetized human participants.36 Additionally, s  tudies of 
c  onditioned taste aversion37–39 provide compelling e  vidence 
Table 3 group means (M) and standard deviations (sD) for average numeric rating scale (nRs) pain intensity scores across calibration 
trials, mean difference between heat pain stimulus temperatures corresponding to nRs pain scores of 6 and 3, and mean difference in 
average nRs pain intensity scores for control cream minus average pain intensity for placebo cream during conditioning trials
Group M (SD)
Mean pain intensity rating  
across calibration trials
Mean temperature  
for NRS of 6 minus mean  
temperature for NRS of 3
Mean pain control cream minus   
mean pain placebo during  
conditioning
Direction 5.18 (1.87) 3.20 (1.15) 1.92 (1.17)
no Verbal + no Direction 4.13 (1.65) 3.07 (1.44) 2.00 (0.93)
Verbal + Direction 4.95 (1.44) 2.80 (0.77) 2.21 (1.13)
Verbal 4.84 (1.12) 2.87 (0.99) 2.59 (1.16)
Verbal + expectation 3.88 (2.85) 3.53 (1.13) 1.85 (1.14)Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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that conditioning in humans is not always c  ognitively medi-
ated. Therefore, while some studies point to the important 
mediating role of explicit expectations in the placebo 
analgesic response, there is sufficient evidence to sug-
gest that conditioning can occur in the absence of explicit 
  expectations leaving open the possibility that placebo 
hypoalgesia could be conditioned without explicit expecta-
tions (ie, via implicit learning).
As such, the third possible explanation is that some 
instances of conditioning are mediated by conscious expec-
tations, while others are not. As Lovibond and Shanks40 
suggest, conditioning without awareness may occur within 
relatively specialized systems, such as the gustatory system 
in conditioned taste aversion. Benedetti and colleagues16,17 
found evidence of a placebo respiratory depression in 
patients previously treated with buprenorphine, who were 
then subsequently administered an infusion of saline and 
told it was buprenorphine, but this effect was not found in 
an unconditioned control group. These researchers note that 
while cognitive and affective mechanisms may be involved 
in placebo analgesia, the mild respiratory depressant effect 
of buprenorphine goes unnoticed by patients, suggesting 
that a conditioning mechanism independent of cognition 
may be involved in accordance with the earlier condition-
ing hypotheses of Wickramasekera41 and Voudouris and 
colleagues.10,23
In another study, Benedetti and colleagues42 found 
that verbally induced expectations of growth hormone 
(GH) increase or decrease produced no change in plasma 
concentration levels, except in subjects who received pre-
conditioning with a GH stimulator. In contrast, verbally 
induced expectations affected pain in healthy subjects and 
motor performance in individuals with Parkinson’s disease.42 
Therefore, conditioning and expectancy mechanisms may 
both be involved in the placebo response; conditioning in 
unconscious processes (eg, hormone secretion and respira-
tory depression) and expectation in conscious processes (eg, 
pain and motor performance).42–44 Additionally, Benedetti’s 
studies involve pharmacological conditioning in contrast to 
the present study and others that use a conditioning paradigm 
without administration of pharmacological agents, and as 
Stewart-Williams and Podd44 point out, this may be a crucial 
difference. Placebo effects in which there is no previous 
experience with a pharmacologically active agent may be 
mediated by explicit expectations whereas placebo effects 
that are not cognitively mediated may occur when a placebo 
mimics pharmacologically active substances with which the 
participant has had previous experience. In the present study, 
only 31 of 75 participants reported any previous experience 
with a local anesthetic cream. It would be interesting for 
future research to explore the present implicit conditioning 
paradigm in subjects who had been preconditioned with 
an active analgesic cream. Additionally, incorporating an 
objective implicit response measure, such as galvanic skin 
response, would provide additional support for implicit asso-
ciative learning mechanisms. It is also possible that there is 
in fact a small effect size for implicit conditioning, and there 
was not sufficient power in the present study to detect group 
differences, given the small sample size.
The second objective of the present study was to examine 
whether asking participants to make their expectations about 
pain explicit has any impact on pain ratings and the magnitude 
of the placebo effect. Results indicated a significant differ-
ence in expected pain ratings, but not in actual pain ratings 
during the final placebo trial. The Verbal + Expectation group 
did not differ from the other groups with respect to their pain 
sensitivity, mean temperature difference between ratings of 
6 and 3, or difference in pain ratings for placebo and control 
during conditioning trials, suggesting that the differences 
between expected and actual pain ratings observed in the 
Verbal + Expectation group were related to the experimental 
manipulation of asking participants to verbalize their expecta-
tions prior to the final trial.
We hypothesized that asking participants to make their 
expectations about pain intensity explicit might enhance 
placebo responding due to demand characteristics, a desire 
to please the experimenter, and/or a desire for consistency 
between their expectations and subsequent experience 
(ie, actual pain r  atings). It is not clear why the placebo effect 
was abolished in this group. One possible explanation is that 
asking p  articipants to rate the amount of pain they expect to 
experience with each cream just prior to the final trial drew 
additional attention to their somatosensory experience, thus 
highlighting the lack of congruence between their expecta-
tions and actual experience. It is also possible that the lack 
of a significant placebo effect in this group is a function of 
sample size.
In summary, although evidence was adduced to s  uggest 
that learning, in the absence of conscious awareness, might 
have occurred as a result of the implicit c  onditioning 
  procedure in some participants, implicit associative l  earning 
was not sufficient to produce a placebo hypoalgesic effect. 
This suggests some level of conscious expectation or 
c  ognitive mediation may be necessary to generate a placebo Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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effect, at least with conditioning paradigms that do not 
involve administration of pharmacological agents. Notably, 
the placebo effect was abolished when expectations for pain 
relief were made explicit, suggesting a delicate interplay 
exists between attention and expectation.
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